Answers are grounded in this paper and cite their sources.
Peroxisome proliferation is inducible in hepatocytes ofrodent and nonrodent species by structurally dissimilar hypolipidemic drugs and certain phthalate ester plasticizers.The induction of peroxisome proliferation appears to be a tissue specific response limited largely to the hepatocyte.Peroxisome proliferation is associated with increases in the activity of the H202-generating peroxisomal fatty acid 3-oxidation system and in the amount of peroxisome proliferation-associated 80,000 MW polypeptide (PPA-80).Chronic adminis- tration of these non-DNA damaging and nonmutagenic peroxisome proliferators to rats and mice results in the development of hepatocellular carcinomas.Comparative morphometric and biochemical data from rats treated with varying dose levels of ciprofibrate, a hypolipidemic drug, and di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate, the widely used plasticizers, indicate that the hepatocarcinogenic potency of these agents is correlatable with their ability to induce peroxisome proliferation, peroxisomal 13-oxidation and PPA-80.Available evidence strongly favors the role of peroxisome proliferation-associated oxidative stress in the induction of liver tumors by peroxisome proliferators.
No takes yet. Share an insight, caveat, or question.
Reddy et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: